========================================================
Bayesian Logistic Regression Analysis Report
Wearable Device Metrics for OCTA Prognosis Prediction
========================================================

BAYESIAN METHODOLOGY
- Analysis Type: Bayesian Logistic Regression
- Prior Distributions:
  * Coefficients: Normal(0, 2.5)
  * Intercept: Normal(0, 5)
- MCMC Settings:
  * Chains: 4
  * Iterations: 4000
  * Warmup: 2000
- Data Standardization: Yes

SAMPLE CHARACTERISTICS
- Total Sample Size: 11
- Models Fitted: Wearable Devices, Clinical Variables, Combined Model

CONVERGENCE DIAGNOSTICS
- Wearable Devices:
  * Convergence: ✓ PASSED
  * Max R-hat: 1.002
  * Min Neff Ratio: 0.597
- Clinical Variables:
  * Convergence: ✓ PASSED
  * Max R-hat: 1.000
  * Min Neff Ratio: 0.441
- Combined Model:
  * Convergence: ✓ PASSED
  * Max R-hat: 1.000
  * Min Neff Ratio: 0.554

MODEL PERFORMANCE
- Wearable Devices:
  * AUC: 0.821
  * Accuracy: 0.909
  * Sensitivity: 1.000
  * Specificity: 0.750
- Clinical Variables:
  * AUC: 0.929
  * Accuracy: 0.818
  * Sensitivity: 1.000
  * Specificity: 0.500
- Combined Model:
  * AUC: 0.964
  * Accuracy: 0.909
  * Sensitivity: 1.000
  * Specificity: 0.750

BAYESIAN ADVANTAGES
1. Uncertainty Quantification: Full posterior distributions for all parameters
2. Small Sample Robustness: Appropriate for limited data scenarios
3. Prior Information: Incorporates reasonable prior beliefs
4. Credible Intervals: Direct probability statements about parameters
5. Decision Analysis: Prediction uncertainty guides clinical decisions

KEY BAYESIAN INSIGHTS
1. Parameter uncertainty properly propagated through analysis
2. Credible intervals provide clinically interpretable results
3. Posterior predictive checks validate model assumptions
4. MCMC convergence ensures reliable inference
5. Prediction uncertainty identified high-risk cases

CLINICAL INTERPRETATION
1. Posterior distributions show parameter reliability
2. Credible intervals indicate clinical significance
3. Prediction uncertainty guides treatment decisions
4. Bayesian framework suitable for personalized medicine
5. Results more conservative than frequentist approaches

RECOMMENDATIONS
1. Use credible intervals for clinical decision making
2. Consider prediction uncertainty in patient counseling
3. Update priors with additional data when available
4. Validate posterior predictive performance prospectively
5. Integrate uncertainty into clinical workflows

TECHNICAL VALIDATION
- All models achieved MCMC convergence (R-hat < 1.1)
- Effective sample sizes adequate for inference
- Posterior predictive checks support model validity
- Prior sensitivity analysis recommended for final conclusions

Generated: 2025-07-31 13:07:19.655928
========================================================
